| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.43 | 0.03 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.03 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |